Shiftwork Disorder with Excessive Sleepiness

Struggling to stay awake when the world is asleep? Consider joining a shift work disorder (SWD) research study.

Eligibility:

• Ages 18 - 65 years old
• Currently experiencing symptoms of Shift Work Disorder (SWD) such as excessive sleepiness and/or insomnia
• Night shift workers with the following schedule:
  • Works at least 5-night shifts per month, with at least shifts being consecutive each month
  • Night shifts must last at least 6 hours between 10:00 pm and 8:00 am, but no longer than 12 hours

» Study Details | Apply for the Study

Narcolepsy Study

If you are experiencing excessive daytime sleepiness due to narcolepsy, consider participating in this study.

Eligibility:

• Be 18-70 years of age
• Experience excessive daytime sleepiness
• Have a primary diagnosis of NT2
• Have a body mass index (BMI) between 18 and 40 kg/m2
• Not having symptoms of narcolepsy due to another medical condition
• Not having untreated uncontrolled sleep apnea
  

There are additional eligibility criteria, which the study team will discuss with participants.

» Study Details | Apply for the Study

Insomnia (Sleeplessness)

This study is a research study testing the safety and effectiveness of an investigational drug, called tasipimidine, to see if it will help treat insomnia (sleeplessness) and how safe it is to use.

You may be eligible to participate in the UNITAS Study if:
• You are 18 to 65 years of age
• You have been diagnosed with insomnia disorder
• It takes you 30 minutes or more to fall asleep, or you are sleeping for 6 hours or less at least 3 nights a week for the past 3 months
• You spend 6 to 9 hours in bed each night

» Study Details | Apply for the Study

Obstructive Sleep Apnea

The EXPLORE-OSA study is evaluating an investigational drug called lorundrostat in adults with moderate to severe obstructive sleep apnea (OSA) and high blood pressure (hypertension). Participants will be in this study for approximately 15 weeks. To qualify for this study, you must be*:

• 18 to 75 years of age
• Diagnosed with moderate to severe OSA and have high blood pressure

» Study Details | Apply for the Study

Narcolepsy and Idiopathic Hypersomnia

The Vibrance Studies are now recruiting people living with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), or idiopathic hypersomnia (IH) to join in research on an investigational oral study drug for the potential treatment of excessive daytime sleepiness symptoms. Learn more to see if you may qualify!

» Study Details | Apply for the Study

Pediatric ADHD Study

Preferred Research Partners is providing a no-cost evaluation to see if your child is eligible for an ADHD research study. If so, a study-related diagnostic work-up, parent education, investigational medication, and compensation up to $400 will be provided.

Eligibility:

• Your child must be 4-5 years old.
• No diagnosis of ADHD is required. 

No insurance is needed. Those who qualify will receive:

• No-cost study-related evaluation and diagnostic work-up.
• No-cost education and counseling for parent/caregiver.
• No-cost investigational medication.
• Compensation up to $400.

» Study Details | Apply for the Study

Major Depressive Disorder (MDD)

Do you struggle with major depressive disorder (MDD)? Contribute to a pivotal psychedelic drug research study that seeks to understand and improve the lives of those affected by major depressive disorder. We are looking for volunteers to participate in a research study with an investigational psychedelic study drug.

Eligibility:

• You must be at least 18 years old and meet the DSM-5 criteria for a diagnosis of MDD.
• You are currently experiencing a major depressive episode of at least 60 days.
• You must be willing to stop taking all current depression medications during the study.
• You have not been diagnosed with uncontrolled diabetes mellitus.
• You are able and willing to adhere to trial requirements, including attending all trial visits and sessions and completing all trial evaluations

» Study Details | Apply for the Study

Major Depressive Disorder

Do you struggle with depression? We are researching a new investigational treatment option to see if it is effective in treating depression. If you suffer from depression, you may be eligible to participate. We are seeking individuals who are:

Ages 18 to 74 years old

Experiencing symptoms of depression

Willing to use a highly effective method of birth control throughout participation

Willingness to stop all medications affecting mood

» Study Details | Apply for the Study

Major Depressive Disorder

Do you struggle with depression? We are researching a new investigational treatment option to see if it is effective in treating depression. If you suffer from depression, you may be eligible to participate. We are seeking individuals who are:

• Ages 18 to 74 years old
• Experiencing symptoms of depression
• Willing to use a highly effective method of birth control throughout participation
• Willingness to stop all medications affecting mood

Fill out the form today to see if you qualify!

» Study Details | Apply for the Study

Social Anxiety

Do you avoid social situations?

We are seeking individuals aged 18-65 who suffer from social anxiety to participate in a clinical study. This study aims to evaluate the efficacy and safety of fasedienol, a potential new treatment designed to provide rapid relief from anxiety when participating in a stressful event. Your participation could contribute to the development of a new therapy that has the potential to improve the quality of life for those struggling with SAD. Who may qualify?

• People who suffer from social anxiety or are diagnosed with SAD

• People who are between the ages of 18 to 65

• People who have a normal functioning sense of smell

» Study Details | Apply for the Study

Major Depressive Disorder (MDD)

Do you struggle with major depressive disorder (MDD)? Contribute to a pivotal psychedelic drug research study that seeks to understand and improve the lives of those affected by major depressive disorder. We are looking for volunteers to participate in a research study with an investigational psychedelic study drug.

Eligibility:

• You must be at least 18 years old and meet the DSM-5 criteria for a diagnosis of MDD.
• You are currently experiencing a major depressive episode of at least 60 days.
• You must be willing to stop taking all current depression medications during the study.
• You have not been diagnosed with uncontrolled diabetes mellitus.
• You are able and willing to adhere to trial requirements, including attending all trial visits and sessions and completing all trial evaluations

» Study Details | Apply for the Study

Adults with Bipolar Disorder Currently Experiencing Depression

Are you feeling sad, down or unmotivated? Taking medication but still experiencing symptoms? You may be eligible for one of our clinic’s research studies aimed at improving mental health.

Eligibility:

• Ages 18-70 years old
• Willing to take an oral investigational medication
• Diagnosed with MDD
• History of Bipolar disorder and currently experiencing depression symptoms
• Taking a stable dose of a mood stabilizer

» Study Details | Apply for the Study

Social Anxiety Disorder

To qualify for this clinical study you must:

• Be 18-65 years old
• Have a social anxiety disorder (does not have to be diagnosed– we will work through the referrals)
• Cannot have had any significant nasal trauma

» Study Details | Apply for the Study

Generalized Anxiety Disorder

Do you struggle with anxiety?

Eligibility:

• Ages 18 to 74 years old
• Experiencing anxiety
  
• Willing to use a highly effective method of birth control throughout the study
• Willing to stop all medication affecting your mood

» Study Details | Apply for the Study

Gastroparesis

Gastroparesis

» Study Details | Apply for the Study

Pediatric Migraines

Does your child struggle with pediatric migraines? They could qualify for this clinical research study.

Eligibility:

• Your child is between the ages of 6-17 years old.
• Your child has been experiencing migraines for at least 6 months.
• Your child has been experiencing between 1 and 14 migraine attacks per month.
  

» Study Details | Apply for the Study

Insomnia in Adolescents Aged 10-17

If your child is at least 10 and under the age of 18 and struggling with insomnia, this study could be for you. An experienced team of researchers is evaluating a medication called Daridorexant, already proven effective and safe in adults, to understand its potential benefits and safety in the younger population.

Eligibility:

• Your child is between 10 and 17 years old.
• Your child struggles with falling asleep and/or staying asleep.
• Chronic insomnia disorder (problems falling asleep, waking up multiple times during the night, early morning awakenings)
• Sleep disturbances have been present for at least 3 months.
• Sleep disturbances occur at least three nights per week.
• Your child does not take naps longer than 1 hour on 3 weekdays per week during the three months before prescreening.
• Sleep problems persist despite adequate time and opportunity for sleep.
• Sleep problems impact daily performance

» Study Details | Apply for the Study

Insomnia in Adolescents Aged 10-17

If your child is at least 10 and under the age of 18 and struggling with insomnia, this study could be for you. An experienced team of researchers is evaluating a medication called Daridorexant, already proven effective and safe in adults, to understand its potential benefits and safety in the younger population.

Eligibility:

• Your child is between 10 and 17 years old.
• Your child struggles with falling asleep and/or staying asleep.
• Chronic insomnia disorder (problems falling asleep, waking up multiple times during the night, early morning awakenings)
• Sleep disturbances have been present for at least 3 months.
• Sleep disturbances occur at least three nights per week.
• Your child does not take naps longer than 1 hour on 3 weekdays per week during the three months before prescreening.
• Sleep problems persist despite adequate time and opportunity for sleep.
• Sleep problems impact daily performance.

» Study Details | Apply for the Study

Pediatric ADHD Study

Preferred Research Partners is providing a no-cost evaluation to see if your child is eligible for an ADHD research study. If so, a study-related diagnostic work-up, parent education, investigational medication, and compensation up to $400 will be provided.

Eligibility:

• Your child must be 4-5 years old.
• No ADHD diagnosis is required. 

No insurance is needed. Those who qualify will receive:

• No-cost study-related evaluation and diagnostic work-up.
• No-cost education and counseling for parent/caregiver.
• No-cost investigational medication.
• Compensation up to $400.
  

» Study Details | Apply for the Study

Upcoming Studies for Men and Women

If would like to submit your information to be contacted for future study opportunities at our Fayetteville location, click to apply here.

» Study Details | Apply for the Study

Pediatric Migraines (Kaleidoscope)

Does your child experience the pain and disability of migraine?

To pre-qualify for this study, your child must:
• Be 6 to 17 years of age and have migraines
• Have 4 to 14 migraine attacks per month with moderate to severe headaches
• Be currently taking or have taken at least 1 oral medication (examples include ibuprofen, Tylenol®, aspirin, Excedrin®, or a prescription medication) for the treatment of a migraine attack.

Additional criteria will be assessed by the study doctor. All study-related visits, tests, and drugs will be provided at no cost. Reimbursement for study-related travel may also be provided.

» Study Details | Apply for the Study

Menstrual Migraine

Do you struggle with migraines during your menstrual cycle? We are looking for volunteers to participate in a research study with an investigational study drug.

Eligibility:

• You must be at least 18 years old
  
• You have at least 1 year history of migraines in at least 2 out of 3 menstrual cycles
  
• You are able and willing to adhere to trial requirements, including attending all trial visits and sessions and completing all trial evaluations

» Study Details | Apply for the Study

Menstrual Migraine

Do you struggle with migraines during your menstrual cycle? We are looking for volunteers to participate in a research study with an investigational study drug.

Eligibility:

• You must be at least 18 years old
  
• You have at least 1 year history of migraines in at least 2 out of 3 menstrual cycles
  
• You are able and willing to adhere to trial requirements, including attending all trial visits and sessions and completing all trial evaluations

There are additional eligibility criteria, which the study team will discuss with participants. If you are interested, additional eligibility criteria will be assessed by the study doctor or staff. Fill out the form to see if you qualify today!

» Study Details | Apply for the Study

Insomnia (Sleeplessness)

This study is a research study testing the safety and effectiveness of an investigational drug, called tasipimidine, to see if it will help treat insomnia (sleeplessness) and how safe it is to use. You may be eligible to participate in the UNITAS Study if:

• You are 18 to 65 years of age
• You have been diagnosed with insomnia disorder
• It takes you 30 minutes or more to fall asleep, or you are sleeping for 6 hours or less at least 3 nights a week for the past 3 months
• You spend 6 to 9 hours in bed each night

» Study Details | Apply for the Study

Social Anxiety

Do you avoid social situations?

We are seeking individuals aged 18-65 who suffer from social anxiety to participate in a clinical study. This study aims to evaluate the efficacy and safety of fasedienol, a potential new treatment designed to provide rapid relief from anxiety when participating in a stressful event. Your participation could contribute to the development of new therapy that has the potential to improve the quality of life for those struggling with SAD. Who may qualify?

• People who suffer from social anxiety or are diagnosed with SAD
• People who are between the ages of 18 to 65
• People who have a normal functioning sense of smell
  

» Study Details | Apply for the Study